↓ Skip to main content

Cochrane Database of Systematic Reviews

Regular treatment with formoterol for chronic asthma: serious adverse events

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
2 X users
wikipedia
16 Wikipedia pages

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
264 Mendeley
Title
Regular treatment with formoterol for chronic asthma: serious adverse events
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd006923.pub3
Pubmed ID
Authors

Christopher J Cates, Matthew J Cates

Abstract

Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Germany 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 258 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 40 15%
Researcher 28 11%
Student > Bachelor 22 8%
Student > Ph. D. Student 19 7%
Student > Postgraduate 17 6%
Other 54 20%
Unknown 84 32%
Readers by discipline Count As %
Medicine and Dentistry 102 39%
Nursing and Health Professions 19 7%
Social Sciences 11 4%
Pharmacology, Toxicology and Pharmaceutical Science 11 4%
Psychology 9 3%
Other 25 9%
Unknown 87 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2019.
All research outputs
#5,150,900
of 25,387,189 outputs
Outputs from Cochrane database of systematic reviews
#7,413
of 12,818 outputs
Outputs of similar age
#32,063
of 170,358 outputs
Outputs of similar age from Cochrane database of systematic reviews
#102
of 183 outputs
Altmetric has tracked 25,387,189 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,818 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.3. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,358 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 183 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.